-
1
-
-
84894493225
-
-
National Diabetes Statistics diabetes.niddk.nih.gov/dm/pubs/statistics (2011, accessed 9 September 2013)
-
National Diabetes Statistics, 2011, diabetes.niddk.nih.gov/dm/pubs/ statistics (2011, accessed 9 September 2013).
-
(2011)
-
-
-
2
-
-
84871852596
-
Update on type 2 diabetes as a cardiovascular disease risk equivalent
-
Kuusisto J, Laakso M. Update on type 2 diabetes as a cardiovascular disease risk equivalent. Curr Cardiol Rep. 2013; 15: 331
-
(2013)
Curr Cardiol Rep
, vol.15
, pp. 331
-
-
Kuusisto, J.1
Laakso, M.2
-
3
-
-
84875462788
-
Impact of diabetes on cardiovascular disease: An update
-
Matheus AS, Tannus LR, Cobas RA, et al. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013; 2013: 653789
-
(2013)
Int J Hypertens
, vol.2013
, pp. 653789
-
-
Matheus, A.S.1
Tannus, L.R.2
Cobas, R.A.3
-
4
-
-
84878218816
-
Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox
-
Costa PZ, Soares R. Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci. 2013; 92: 1037-1045
-
(2013)
Life Sci
, vol.92
, pp. 1037-1045
-
-
Costa, P.Z.1
Soares, R.2
-
5
-
-
84872769604
-
Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes
-
Galassetti P. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes. Exp Diabetes Res. 2012; 2012: 943706
-
(2012)
Exp Diabetes Res
, vol.2012
, pp. 943706
-
-
Galassetti, P.1
-
6
-
-
84878690214
-
The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress
-
Guo R, Liu B, Zhou S, et al. The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress. Biomed Res Int. 2013; 2013: 430791
-
(2013)
Biomed Res Int
, vol.2013
, pp. 430791
-
-
Guo, R.1
Liu, B.2
Zhou, S.3
-
7
-
-
84872313601
-
Mechanisms of diabetic complications
-
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93: 137-188
-
(2013)
Physiol Rev
, vol.93
, pp. 137-188
-
-
Forbes, J.M.1
Cooper, M.E.2
-
8
-
-
84863115343
-
Role and function of macrophages in the metabolic syndrome
-
Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J. 2012; 442: 253-262
-
(2012)
Biochem J
, vol.442
, pp. 253-262
-
-
Bhargava, P.1
Lee, C.H.2
-
9
-
-
84878574279
-
Sirtuins as possible drug targets in type 2 diabetes
-
Kitada M, Kume S, Kanasaki K, et al. Sirtuins as possible drug targets in type 2 diabetes. Curr Drug Targets. 2013; 14: 622-636
-
(2013)
Curr Drug Targets
, vol.14
, pp. 622-636
-
-
Kitada, M.1
Kume, S.2
Kanasaki, K.3
-
10
-
-
84878525986
-
Oxidative stress in vascular disease and its pharmacological prevention
-
Li H, Horke S, Förstermann U. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci. 2013; 34: 313-319
-
(2013)
Trends Pharmacol Sci
, vol.34
, pp. 313-319
-
-
Li, H.1
Horke, S.2
Förstermann, U.3
-
11
-
-
84859201009
-
Resveratrol, wine, and atherosclerosis
-
Prasad K. Resveratrol, wine, and atherosclerosis. Int J Angiol. 2012; 21: 7-18
-
(2012)
Int J Angiol
, vol.21
, pp. 7-18
-
-
Prasad, K.1
-
12
-
-
84867865164
-
Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action
-
Xu Q, Si LY. Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action. Nutr Res. 2012; 32: 648-658
-
(2012)
Nutr Res
, vol.32
, pp. 648-658
-
-
Xu, Q.1
Si, L.Y.2
-
13
-
-
0031561513
-
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
-
Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275: 218-220
-
(1997)
Science
, vol.275
, pp. 218-220
-
-
Jang, M.1
Cai, L.2
Udeani, G.O.3
-
14
-
-
2542445157
-
Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: A mechanistic approach to the design of COX-1 selective agents
-
Szewczuk LM, Forti L, Stivala LA, et al. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. 2004; 279: 22727-22737
-
(2004)
J Biol Chem
, vol.279
, pp. 22727-22737
-
-
Szewczuk, L.M.1
Forti, L.2
Stivala, L.A.3
-
15
-
-
84868598670
-
SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice
-
Stein S, Schäfer N, Breitenstein A, et al. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging (Albany NY). 2010; 2: 353-360
-
(2010)
Aging (Albany NY)
, vol.2
, pp. 353-360
-
-
Stein, S.1
Schäfer, N.2
Breitenstein, A.3
-
16
-
-
0035669040
-
Resveratrol inhibits TNF alpha-induced endothelial cell activation
-
Bertelli AA, Baccalini R, Battaglia E, et al. Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie. 2001; 56: 613-616
-
(2001)
Therapie
, vol.56
, pp. 613-616
-
-
Bertelli, A.A.1
Baccalini, R.2
Battaglia, E.3
-
17
-
-
0037387575
-
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: Antiatherogenic properties of Mediterranean diet phytochemicals
-
Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol. 2003; 23: 622-629
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 622-629
-
-
Carluccio, M.A.1
Siculella, L.2
Ancora, M.A.3
-
18
-
-
79551601710
-
Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1- independent pathway
-
Kitada M, Kume S, Imaizumi N, et al. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes. 2011; 60: 634-643
-
(2011)
Diabetes
, vol.60
, pp. 634-643
-
-
Kitada, M.1
Kume, S.2
Imaizumi, N.3
-
19
-
-
13344259300
-
Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
-
Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996; 84: 491-495
-
(1996)
Cell
, vol.84
, pp. 491-495
-
-
Chen, H.1
Charlat, O.2
Tartaglia, L.A.3
-
20
-
-
0033956846
-
The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of Western diet feeding
-
Kobayashi K, Forte TM, Taniguchi S, et al. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism. 2000; 49: 22-31
-
(2000)
Metabolism
, vol.49
, pp. 22-31
-
-
Kobayashi, K.1
Forte, T.M.2
Taniguchi, S.3
-
21
-
-
0037092995
-
Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management
-
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002; 287: 2570-2581
-
(2002)
JAMA
, vol.287
, pp. 2570-2581
-
-
Beckman, J.A.1
Ma, C.2
Libby, P.3
-
23
-
-
61949439551
-
Endothelial dysfunction in diabetes: From mechanisms to therapeutic targets
-
Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009; 16: 94-112
-
(2009)
Curr Med Chem
, vol.16
, pp. 94-112
-
-
Potenza, M.A.1
Gagliardi, S.2
Nacci, C.3
-
24
-
-
80052164831
-
Monocytes link atherosclerosis and cancer
-
Pittet MJ, Swirski FK. Monocytes link atherosclerosis and cancer. Eur J Immunol. 2011; 41: 2519-2522
-
(2011)
Eur J Immunol
, vol.41
, pp. 2519-2522
-
-
Pittet, M.J.1
Swirski, F.K.2
-
25
-
-
18244370762
-
Inflammation, stress, and diabetes
-
Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005; 115: 1111-1119
-
(2005)
J Clin Invest
, vol.115
, pp. 1111-1119
-
-
Wellen, K.E.1
Hotamisligil, G.S.2
-
26
-
-
0142029561
-
Diabesity: An inflammatory metabolic condition
-
Schmidt MI, Duncan BB. Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med. 2003; 41: 1120-1130
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 1120-1130
-
-
Schmidt, M.I.1
Duncan, B.B.2
-
27
-
-
34447274305
-
Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell
-
Haubner F, Lehle K, Münzel D, et al. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant- protein-1 in the diabetic endothelial cell. Biochem Biophys Res Commun. 2007; 360: 560-565
-
(2007)
Biochem Biophys Res Commun
, vol.360
, pp. 560-565
-
-
Haubner, F.1
Lehle, K.2
Münzel, D.3
-
28
-
-
5644251770
-
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus
-
Simeoni E, Hoffmann MM, Winkelmann BR, et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia. 2004; 47: 1574-1580
-
(2004)
Diabetologia
, vol.47
, pp. 1574-1580
-
-
Simeoni, E.1
Hoffmann, M.M.2
Winkelmann, B.R.3
-
29
-
-
33846023697
-
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: Relationship to cholesterol turnover
-
Bláha V, Andrýs C, Smahelová A, et al. Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover. Pharmacol Res. 2006; 54: 421-428
-
(2006)
Pharmacol Res
, vol.54
, pp. 421-428
-
-
Bláha, V.1
Andrýs, C.2
Smahelová, A.3
-
30
-
-
70449412663
-
Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals
-
Piemonti L, Calori G, Lattuada G, et al. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals. Diabetes Care. 2009; 32: 2105-2110
-
(2009)
Diabetes Care
, vol.32
, pp. 2105-2110
-
-
Piemonti, L.1
Calori, G.2
Lattuada, G.3
-
31
-
-
84355162997
-
Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients
-
Lenghel AR, Kacso IM, Bondor CI, et al. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract. 2012; 95: 55-61
-
(2012)
Diabetes Res Clin Pract
, vol.95
, pp. 55-61
-
-
Lenghel, A.R.1
Kacso, I.M.2
Bondor, C.I.3
-
32
-
-
77951291604
-
Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus
-
Nomura S, Inami N, Shouzu A, et al. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets. 2009; 20: 406-414
-
(2009)
Platelets
, vol.20
, pp. 406-414
-
-
Nomura, S.1
Inami, N.2
Shouzu, A.3
-
33
-
-
69849097164
-
Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus
-
Jin C, Lu L, Zhang RY, et al. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clin Chim Acta. 2009; 408: 45-49
-
(2009)
Clin Chim Acta
, vol.408
, pp. 45-49
-
-
Jin, C.1
Lu, L.2
Zhang, R.Y.3
-
34
-
-
0347334429
-
Obesity, adiponectin and vascular inflammatory disease
-
Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003; 14: 561-566
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 561-566
-
-
Ouchi, N.1
Kihara, S.2
Funahashi, T.3
-
35
-
-
0030615201
-
Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
-
Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336: 1066-1071
-
(1997)
N Engl J Med
, vol.336
, pp. 1066-1071
-
-
Barnes, P.J.1
Karin, M.2
-
36
-
-
38749112555
-
Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction
-
Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008; 54: 24-38
-
(2008)
Clin Chem
, vol.54
, pp. 24-38
-
-
Packard, R.R.1
Libby, P.2
-
37
-
-
79957581507
-
Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells
-
Lamers D, Schlich R, Greulich S, et al. Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J Cell Mol Med. 2011; 15: 1177-1188
-
(2011)
J Cell Mol Med
, vol.15
, pp. 1177-1188
-
-
Lamers, D.1
Schlich, R.2
Greulich, S.3
-
38
-
-
13344261982
-
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
-
Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996; 97: 1715-1722
-
(1996)
J Clin Invest
, vol.97
, pp. 1715-1722
-
-
Brand, K.1
Page, S.2
Rogler, G.3
-
39
-
-
33244486764
-
Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells
-
Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 2006; 4: e31
-
(2006)
PLoS Biol
, vol.4
, pp. 31
-
-
Bordone, L.1
Motta, M.C.2
Picard, F.3
-
40
-
-
27744518040
-
FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction
-
Kitamura YI, Kitamura T, Kruse JP, et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005; 2: 153-163
-
(2005)
Cell Metab
, vol.2
, pp. 153-163
-
-
Kitamura, Y.I.1
Kitamura, T.2
Kruse, J.P.3
-
41
-
-
33744946526
-
Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats
-
Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006; 290: E1339 - E1346
-
(2006)
Am J Physiol Endocrinol Metab
, vol.290
-
-
Su, H.C.1
Hung, L.M.2
Chen, J.K.3
-
42
-
-
34548857700
-
SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B
-
Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007; 6: 307-319
-
(2007)
Cell Metab
, vol.6
, pp. 307-319
-
-
Sun, C.1
Zhang, F.2
Ge, X.3
-
43
-
-
0141719702
-
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
-
Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425: 191-196
-
(2003)
Nature
, vol.425
, pp. 191-196
-
-
Howitz, K.T.1
Bitterman, K.J.2
Cohen, H.Y.3
-
44
-
-
3943071801
-
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
-
Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004; 430: 686-689
-
(2004)
Nature
, vol.430
, pp. 686-689
-
-
Wood, J.G.1
Rogina, B.2
Lavu, S.3
-
45
-
-
12244285648
-
Human, rat, and mouse metabolism of resveratrol
-
Yu C, Shin YG, Chow A, et al. Human, rat, and mouse metabolism of resveratrol. Pharm Res. 2002; 19: 1907-1914
-
(2002)
Pharm Res
, vol.19
, pp. 1907-1914
-
-
Yu, C.1
Shin, Y.G.2
Chow, A.3
-
46
-
-
84865130936
-
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice
-
Do GM, Jung UJ, Park HJ, et al. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res. 2012; 56: 1282-1291
-
(2012)
Mol Nutr Food Res
, vol.56
, pp. 1282-1291
-
-
Do, G.M.1
Jung, U.J.2
Park, H.J.3
-
47
-
-
84878299056
-
Resveratrol attenuates hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells
-
Liu L, Gu L, Ma Q, et al. Resveratrol attenuates hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells. Eur Rev Med Pharmacol Sci. 2013; 17: 88-94
-
(2013)
Eur Rev Med Pharmacol Sci
, vol.17
, pp. 88-94
-
-
Liu, L.1
Gu, L.2
Ma, Q.3
-
48
-
-
84863243411
-
Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase
-
Ku CR, Lee HJ, Kim SK, et al. Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J. 2012; 59: 103-109
-
(2012)
Endocr J
, vol.59
, pp. 103-109
-
-
Ku, C.R.1
Lee, H.J.2
Kim, S.K.3
-
49
-
-
84873720266
-
Resveratrol improves diabetic retinopathy possibly through oxidative stress - Nuclear factor κb - Apoptosis pathway
-
Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway. Pharmacol Rep. 2012; 64: 1505-1514
-
(2012)
Pharmacol Rep
, vol.64
, pp. 1505-1514
-
-
Soufi, F.G.1
Mohammad-Nejad, D.2
Ahmadieh, H.3
-
50
-
-
84874729032
-
Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats
-
Soufi FG, Vardyani M, Sheervalilou R, et al. Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats. Gen Physiol Biophys. 2012; 31: 431-438
-
(2012)
Gen Physiol Biophys
, vol.31
, pp. 431-438
-
-
Soufi, F.G.1
Vardyani, M.2
Sheervalilou, R.3
-
51
-
-
84862306635
-
Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: Mechanistic insights
-
Yun JM, Chien A, Jialal I, et al. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem. 2012; 23: 699-705
-
(2012)
J Nutr Biochem
, vol.23
, pp. 699-705
-
-
Yun, J.M.1
Chien, A.2
Jialal, I.3
-
52
-
-
77956465167
-
Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes
-
Liu FC, Hung LF, Wu WL, et al. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res Ther. 2010; 12: R167
-
(2010)
Arthritis Res Ther
, vol.12
, pp. 167
-
-
Liu, F.C.1
Hung, L.F.2
Wu, W.L.3
-
53
-
-
84877002108
-
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
-
Tomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, et al. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res. 2013; 72: 69-82
-
(2013)
Pharmacol Res
, vol.72
, pp. 69-82
-
-
Tomé-Carneiro, J.1
Larrosa, M.2
Yáñez-Gascón, M.J.3
-
54
-
-
84865181393
-
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
-
Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012; 32: 537-541
-
(2012)
Nutr Res
, vol.32
, pp. 537-541
-
-
Bhatt, J.K.1
Thomas, S.2
Nanjan, M.J.3
-
55
-
-
80052910300
-
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
-
Brasnyó P, Molnár GA, Mohás M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011; 106: 383-389
-
(2011)
Br J Nutr
, vol.106
, pp. 383-389
-
-
Brasnyó, P.1
Molnár, G.A.2
Mohás, M.3
|